Lotus Pharmaceuticals, Inc. (LTUS)
OTCMKTS · Delayed Price · Currency is USD
0.0083
+0.0029 (54.67%)
At close: Aug 8, 2025
Lotus Pharmaceuticals Company Description
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company is based in Nashville, Tennessee.
Lotus Pharmaceuticals, Inc.
| Country | United States |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 383 |
| CEO | Zhong Yi Liu |
Contact Details
Address: 813 Blue Ridge Drive Nashville, Nevada 37207 United States | |
| Phone | 615 310 2688 |
| Website | lotuspharmaceuticalsusa.com |
Stock Details
| Ticker Symbol | LTUS |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US5457152032 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Zhong Yi Liu | Founder, Chairman, Chief Executive Officer and President |
| Yan Zeng | Chief Financial Officer and Principal Accounting Officer |
| Dr. Xing Shen | Vice President of Corporate Development |